Addus HomeCare Corporation’s executive vice president, Roberton James Stevenson, sold 567 shares of the company’s stock on February 24, 2024. The shares were sold at an average price of $107.35 each, resulting in a total transaction value of $60,867.45. Following this sale, Stevenson holds 14,314 shares in the company, which are now valued at approximately $1,536,607.90. This transaction represents a 3.81% decrease in his ownership of Addus HomeCare.
The sale was documented in a filing with the Securities and Exchange Commission (SEC), which can be accessed through the SEC’s official website. This event is part of a broader context of stock activity surrounding Addus HomeCare, a significant player in the home and community-based care sector.
Current Stock Performance
On February 23, 2024, shares of Addus HomeCare opened at $103.29, with a twelve-month low of $88.96 and a high reaching $124.43. The company currently has a market capitalization of $1.91 billion, with a price-to-earnings (P/E) ratio of 19.83 and a debt-to-equity ratio of 0.11. These figures indicate a stable financial position, supported by a current ratio of 1.80 and a quick ratio of 1.66. The stock’s fifty-day moving average stands at $109.41, while the two-hundred day moving average is $113.01.
Analysts’ Perspectives on Addus HomeCare
Addus HomeCare has attracted attention from several financial analysts. In a report dated November 13, 2024, BMO Capital Markets initiated coverage with a “market perform” rating and a price target of $120.00. Meanwhile, Stephens recently revised their price target from $140.00 to $135.00, maintaining an “overweight” rating. Barclays also adjusted its price objective from $117.00 to $112.00, rating the stock as “underweight.”
In contrast, Weiss Ratings reaffirmed a “hold (c+)” rating in a report issued on January 21, 2024. Additionally, TD Cowen reiterated a “buy” rating for the stock in a research note from November 5, 2024. Market analysts currently have varying opinions on the stock: one analyst rates it as a Strong Buy, seven have assigned Buy ratings, two have issued Hold ratings, and one has given it a Sell rating. According to data from MarketBeat, Addus HomeCare holds a consensus rating of “Moderate Buy” with a price target averaging $134.33.
Addus HomeCare remains a significant entity in the health care sector, primarily focused on providing essential home care services for elderly, disabled, and medically complex individuals throughout the United States. The company’s services include non-medical personal care and licensed home health support, aimed at enhancing clients’ independence and quality of life.
